Very nice presentation on ligandomics-based treatment selection for personalized vaccination approaches. Prof Juliane Waltz summarised the state-of-the-art...with adjuvant application for #peptide or #mrna vaccines in #Oncology being the current field with promising results. #Immunotherapy combinations bring up the questions: when? What target? And so on... Plenty of aspects to explore! Immunotherapy of cancer conference #ITOC11 #immunology #science #health
